Events

In this course you will get many tips and tricks on how to choose the most effective tactics to reach the goals set in the Medical Plan, and on how to optimally plan and execute them throughout the year. Participate in this course for the unique opportunity to gain advice for your specific questions from a true Medical Affairs expert.

The goal of this course is to equip senior biotech and pharma executives with best practices to prepare for and execute every step of the process. You will acquire the most critical out-licensing skills, concepts, and tools. By participating, you will not only have the chance to ask your specific questions of a true expert, but also experience the unique opportunity to share experiences and engage in in-depth discussions with your international peers.

Achieving global commercial launch success requires an early start—beginning as early as proof of concept—along with specialised expertise and seamless cross-functional collaboration. This course equips you with all the concepts, evidence-based tools, and strategic insights to make informed decisions and effectively plan every step towards a successful global launch.

The goal of this course is to demystify market access for anyone involved. You will be equipped with clear schematic overviews of the market access systems in Europe’s major markets as a resource for reference in your daily work.

This one-day programme will set you up for success as a Medical Affairs professional in this era of digital transformation.

This course, led by two of Europe’s most respected forecasting experts in pharma, will teach you the evidence-based concepts, models and techniques that work best to forecast the sales of pharmaceuticals.

This one-day programme empowers Commercial and Medical Affairs managers to become highly effective contributors to the cross-functional process required for a successful omnichannel pharma brand launch.

To optimise successful transactions and partnerships, companies need a structured business development and licensing process, and all contributors need to understand the whole process. This course offers a unique opportunity to speed up your learning curve by giving you a comprehensive overview of the licensing process in the context of business development in the pharma-biotech world.

Attending this course is a crucial investment for leaders and key contributors in a country launch team because it offers comprehensive insights and practical tools to manage successful product launches.

Real World Evidence (RWE) has become an essential addition to Randomised Controlled Trials (RCTs) to further reduce regulatory, payer, physician and patient uncertainty. Unfortunately, many companies struggle implementing it. The key ingredient to success is a cross-functional organisation where managers have widespread knowledge of the fundamentals and a shared vocabulary. In this course you will learn the fundamentals of RWE so that you can contribute effectively when decisions are made and/or when implementing RWE studies.

Most countries have their own Health Technology Assessment (HTA) body with specific views about which criteria to be used and how the HTA process should be conducted. On top of that, EU-level networks strive for a more efficient use of resources and increased collaboration between all stakeholders involved. In this 1-day course you will learn how companies should optimise processes and criteria in this complex environment.

This course will equip you with the knowledge and tools to engage effectively with the right key opinion leaders at the right time in a product’s lifecycle, ensuring the strategic needs of your products are met, as set out in the Medical/Brand Plan.